Dr. Farag, associate professor of medicine and a researcher with the Indiana University School of Medicine, will set the overall direction and development of the cancer center’s clinical research program. He will be responsible for recognizing promising areas of research and providing direction to faculty in pursuing research objectives.
Dr. Farag is also director of the Hematological Malignancies Program and the Bone Marrow and Stem Cell Transplantation Program at the cancer center.
Dr. Farag previously was the director of the Multiple Myeloma Program and medical director of the Bone Marrow Transplantation Laboratory at the Ohio State University Comprehensive Cancer Center and the Clinical Hematology and Stem Cell Transplantation Program at the University of Queensland in Australia.
As a member of the Hematopoiesis, Microenvironment and Immunology Program at the IU Simon Cancer Center, Dr. Farag’s research is focused on the development of novel approaches to hematopoietic stem cell transplantation, including safer approaches to alternate donor transplantation. He also is focused on the development of novel agents and regimens for the treatment of multiple myeloma, including pre-clinical research of new drug development.
Certified in internal medicine, clinical hematology, and hematopathology by the Royal Colleges of Physicians and Pathologists in Australia, Dr. Farag is an active member of the American Society of Clinical Oncology, the American Society of Hematology, the American Society for Blood and Marrow Transplantation, and the International Society for Cellular Therapy. He also served as a panel member of the National Comprehensive Cancer Network for Multiple Myeloma.
A graduate of the University of Melbourne, Dr. Farag completed his residency training at the Royal Melbourne Hospital in internal medicine. He completed a fellowship in clinical hematology at St. Vincent’s Hospital in Melbourne and additional training in bone marrow transplantation at Roswell Park Cancer Institute in Buffalo, N.Y.